Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patients
Autor: | Camilla I. Svensson, Payam Emami Khoonsari, Kim Kultima, Lars Tanum, Stephanie Herman, Sravani Musunri, Torsten Gordh |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male Proteomics 0301 basic medicine Fibromyalgia Proteome Population Biophysics Context (language use) Bioinformatics Biochemistry 03 medical and health sciences Cerebrospinal fluid Antigens Neoplasm Malate Dehydrogenase Biomarkers Tumor medicine Humans Shotgun proteomics education Aged Apolipoprotein C-III Univariate analysis education.field_of_study 030102 biochemistry & molecular biology business.industry Neuropeptides Proteins Middle Aged medicine.disease 030104 developmental biology Case-Control Studies Female business Biomarkers Biomedical sciences |
Zdroj: | Journal of Proteomics. 190:35-43 |
ISSN: | 1874-3919 |
DOI: | 10.1016/j.jprot.2018.04.014 |
Popis: | Fibromyalgia (FM) is a syndrome characterized by widespread muscular pain, fatigue and functional symptoms, which is known to be difficult to diagnose as the various symptoms overlap with many other conditions. Currently, there are no biomarkers for FM, and the diagnosis is made subjectively by the clinicians. We have performed shotgun proteomics on cerebrospinal fluid (CSF) from FM patients and non-pain controls to find potential biomarker candidates for this syndrome. Based on our multivariate and univariate analyses, we found that the relative differences in the CSF proteome between FM patients and controls were moderate. Four proteins, important to discriminate FM patients from non-pain controls, were found: Apolipoprotein C-III, Galectin-3-binding protein, Malate dehydrogenase cytoplasmic and the neuropeptide precursor protein ProSAAS. These proteins are involved in lipoprotein lipase (LPL) activity, inflammatory signaling, energy metabolism and neuropeptide signaling. SIGNIFICANCE: Fibromyalgia is present in as much as 2% of the population, causing pain, stiffness, and tenderness of the muscles. Upon accurate diagnostic, nonpharmacological and pharmacological therapies can be used to alleviate pain and manage other symptoms. However, lack of objective, universal applicable diagnostic criteria as well as vague and diffused symptoms, have made diagnosis difficult. In this context, our findings can shed light on potential value of CSF proteome for objectively diagnosing FM. |
Databáze: | OpenAIRE |
Externí odkaz: |